MedSurg and Neurotechnology — Selling, general and administrative expenses
Stryker MedSurg and Neurotechnology — Selling, general and administrative expenses decreased by 1.2% to $972.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 24.6%, from $780.00M to $972.00M. Over 2 years (FY 2022 to FY 2024), MedSurg and Neurotechnology — Selling, general and administrative expenses shows an upward trend with a 11.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A lower ratio of SG&A to revenue indicates higher operational efficiency and better scalability of the business model.
Detailed definition
Encompasses the overhead costs required to operate the MedSurg and Neurotechnology segment, including sales force commis...
Peer comparison
Standard operating expense metric for all public companies, comparable across the medical device industry.
syk_segment_medsurg_and_neurotechnology_selling_general_and_administrative_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $641.00M | $641.00M | $641.00M | $641.00M | $733.50M | $733.50M | $733.50M | $733.50M | $763.00M | $775.00M | $780.00M | $885.00M | $937.00M | $984.00M | $972.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +14.4% | +0.0% | +0.0% | +0.0% | +4.0% | +1.6% | +0.6% | +13.5% | +5.9% | +5.0% | -1.2% |
| YoY Change | — | — | — | — | +14.4% | +14.4% | +14.4% | +14.4% | +4.0% | +5.7% | +6.3% | +20.7% | +22.8% | +27.0% | +24.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology — selling, general and administrative expenses?
- Stryker (SYK) reported medsurg and neurotechnology — selling, general and administrative expenses of $972.00M in Q3 2025.
- How has Stryker's medsurg and neurotechnology — selling, general and administrative expenses changed year-over-year?
- Stryker's medsurg and neurotechnology — selling, general and administrative expenses increased by 24.6% year-over-year, from $780.00M to $972.00M.
- What is the long-term trend for Stryker's medsurg and neurotechnology — selling, general and administrative expenses?
- Over 2 years (2022 to 2024), Stryker's medsurg and neurotechnology — selling, general and administrative expenses has grown at a 11.8% compound annual growth rate (CAGR), from $2.56B to $3.20B.
- What does medsurg and neurotechnology — selling, general and administrative expenses mean?
- The operating costs to sell products and manage the business segment, excluding production costs.